Operating Lease, Right-of-Use Asset of Day One Biopharmaceuticals, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Day One Biopharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Day One Biopharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $2,342,000, a 3.3% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Day One Biopharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,342,000 -$80,000 -3.3% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $2,450,000 -$124,000 -4.8% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $2,499,000 +$2,335,000 +1424% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $2,577,000 +$2,318,000 +895% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $2,422,000 +$2,070,000 +588% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $2,574,000 +$2,132,000 +482% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $164,000 -$366,000 -69% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $259,000 -$357,000 -58% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $352,000 -$347,000 -50% 31 Dec 2023 10-K/A 06 Mar 2025 2024 FY
Q3 2023 $442,000 -$422,000 -49% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $530,000 -$463,000 -47% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $616,000 +$436,000 +242% 31 Mar 2023 10-Q 01 May 2023 2023 Q1
Q4 2022 $699,000 +$472,000 +208% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $864,000 +$591,000 +216% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $993,000 +$674,000 +211% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $180,000 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $227,000 -$179,000 -44% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 $273,000 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $319,000 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q4 2020 $406,000 31 Dec 2020 10-K 07 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.